Bowel Management Systems Market Size, Share & Trends Analysis Report By Product (Colostomy Bags, Irrigation System, Nerve Modulation Devices and Accessories), By Patient Type (Adult, Pediatric), By End-User (Home Care, Hospitals, Ambulatory Surgery Centers), By Regions (North America, Europe, Asia-Pacific, LAMEA) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Market Overview

The global bowel management systems market size was valued at USD 2.27 billion in 2022. It is estimated to reach USD 3.21 billion by 2031, growing at a CAGR of 3.7% during the forecast period (2023–2031). Factors such as rising incidence of irritable bowel syndrome and growing prospects in emerging economies, significantly drives the bowel management systems market demand by 2031.

A bowel management system controls the containment of liquid or semi-liquid stools. It is applied to people with fecal incontinence to protect their skin from pollutants and moisture that could lead to skin damage. Containing infected body waste in a closed system decreases the spread of infection. It also offers protection by supporting the sacral and perianal pressure points. The chance of unintentional stool leakage and constipation can be greatly reduced by using bowel management systems or devices such as colostomy bags, irrigation systems, etc.

Additionally, people with irritable bowel syndrome and gastrointestinal and colorectal cancer are more likely to experience fecal irregularity. Fecal irregularity is another common complaint among older people. The bowel management system is designed to safely and effectively channel excrement, shield patients' wounds from fecal contamination, reduce the danger of skin deterioration and infection growth, and shield patients' wounds from fecal contamination. They are made of a pure substance that won't give anyone who uses them an allergic response. These objectives laid the groundwork for the creation of their system.

Highlights

• Colostomy bags dominate the product segment.
• Adults dominate the patient type segment.
• Hospital dominates the end-user segment.
• North America is the highest shareholder in the global market.

Market Dynamics

Global bowel management systems market drivers:

Rising incidence of irritable bowel syndrome

Irritable bowel syndrome (IBS), also called inflammatory bowel disease (IBD), causes digestive system inflammation. This inflammation can result from numerous symptoms, such as abdominal pain, severe diarrhea, fatigue, weight loss, and famine. The most prevalent complaints among people with this illness are constipation and fecal incontinence. Irritable bowel syndrome prevalence has increased significantly globally over the past few years, with unambiguous evidence of this increase. For example, estimates from the American College of Gastroenterology state that between 10 and 15% of adult Americans suffer from symptoms consistent with irritable bowel syndrome (IBS). It is therefore projected that the market for bowel management systems will experience growth in the not-too-distant future as irritable bowel syndrome prevalence increases around the globe; this is because one of the most prevalent digestive ailments is irritable bowel syndrome.

Increasing attention to and awareness of bowel health

People are growing more conscious of the importance of maintaining healthy bowels and efficiently treating intestinal disorders. As the number of people with digestive problems keeps increasing, this topic is receiving more attention. This emphasis has emerged due to the increasing population suffering from intestinal dysfunction. It is a positive sign since it suggests that more individuals are starting to understand the importance of the two habits we previously talked about.

Patients and those responsible for their care increasingly understand the need to take action to manage bowel movements. Patients and those who supply them with care can attest to this fact. It is advantageous for all parties involved because physicians and other medical experts emphasize the procedures described above in the previous paragraphs. This information has directly increased the need for bowel management tools, which has sparked the development of new, cutting-edge, and creative technology.

Global bowel management systems market restraint:

General shortage of professionals

There are currently few guidelines that specifically address the treatment of the bowels for bedridden patients who are experiencing fecal irregularity despite the government having produced many recommendations on palliative care during the past few years. It has been noted that the fear of losing their dignity is one of the main worries of persons with disorders that affect how well their bowels function. This typically results from a decreased capacity to manage their body functions and a loss of privacy, especially while performing personal care, like taking a shower, using the restroom, and performing bowel treatments. In addition, the lack of skilled experts necessary to increase patients' comfort levels throughout treatments related to the management of their intestines is another serious concern, particularly in developing nations. This shortage is problematic because these specialists are essential for raising patient comfort levels.

Global bowel management systems market opportunities:

Growing prospects in emerging economies

The growing nations of the Asia-Pacific and LAMEA regions provide lucrative prospects for expanding the bowel management systems market due to improved healthcare infrastructure and a rise in demand for better healthcare. Some of the world's fastest-growing populations reside in these areas. The demand for bowel management systems is impacted by the rise in autoimmune diseases like irritable bowel syndrome, which can lead to constipation or fecal inconsistency, as well as the amount of research necessary to develop medical devices for managing feces. Additionally, the surge in healthcare reforms in emerging countries is anticipated to open lucrative market expansion opportunities. The rise of investments in healthcare and R&D in developing nations like China, India, and Brazil aids the growth of the business.

Regional Analysis

Based on region, the global bowel management systems market share is bifurcated into North America, Europe, Asia-Pacific, and LAMEA.

North america dominates the global market

North America is the most significant global bowel management systems market shareholder and is estimated to exhibit a CAGR of 3.51% over the forecast period. Continuous research and development directed at the innovation of novel bowel management devices for excrement management is the predominant trend in the North American market for bowel management systems. This is the most prominent development direction that can be identified. This development path focuses predominantly on excretion management. The market is also growing as a result of the rising amount of people in the area retiring at an increasingly rapid rate.

According to the Economics and Statistics Administration of the U.S. Department of Commerce, the old population in the United States is growing at a very slow rate. In the not-too-distant future, the proportion of older adults in the total population is anticipated to increase much faster. According to the "middle series" projections of the Census Bureau, the population of people aged 65 and older is anticipated to more than triple by 2050, reaching 80 million people. These projections are based on the current population. Consequently, this region's rapidly expanding senior population is anticipated to be a significant factor in the bowel management systems market growth. This is because the senior population in this region is rapidly growing.

Asia-Pacific is anticipated to exhibit a CAGR of 6.0% over the forecast period. The rise in government initiatives to improve the healthcare sector, the rising per capita income in many nations, and the increased focus of top manufacturers on expanding their geographic presence in developing Asia-Pacific nations to seize high-growth market opportunities are the primary factors propelling the bowel management systems market growth in the region. In addition, ConvaTec and Coloplast, among other top producers of bowel management systems, are steadily concentrating on this market to launch their products. The market in this region is also growing due to the demand for these goods brought on by an increase in irritable bowel syndrome.

Europe is predicted to grow significantly over the forecast period. The availability of bowel management devices will likely become more widely known to patients in European nations, which is expected to spur market expansion. Additionally, rising government support for innovation and increased financing for projects involving the R&D of novel fecal management systems contribute to market expansion in this area. The expansion of bowl dysfunction syndromes, a significant development in healthcare infrastructure, and the accessibility of these devices in this area all support market expansion.

LAMEA is expected to have substantial growth in the next years due to a growing knowledge of cystic fibrosis treatments and improved healthcare infrastructure. Recent developments in the disease's detection and treatment have drastically altered the situation, leading to a significant increase in survival. Brazil's current CF neonatal screening program has full coverage, and most states have referral clinics for the ongoing care of those with the condition.

Segmental Analysis

The global bowel management systems market is bifurcated into product, patient type, and end-user.

Based on the product, the global market is bifurcated into colostomy bags, irrigation systems, and nerve modulation devices and accessories.

The colostomy bags segment dominates the global market and is projected to exhibit a CAGR of 3.8% over the forecast period. Colostomy bags are particular plastic bags used to collect feces released from the digestive tract through a stoma, or opening, in the abdominal wall. It is possible to have this opening made for you if you have a colostomy. When a colostomy operation is complete, the stoma will be cleaned and prepared for the attending physician to connect the colostomy bag. Patients with fecal inconsistency widely use colostomy bags as necessary medical gear to treat their symptoms.

Some groups that utilize these things frequently include elderly folks, those bedridden, and those with irritable bowel syndrome. People who experience different digestive issues are among other groups. In the not-too-distant future, an increase in the number of older adults living in every region of the world and an increase in people's awareness of the use of colostomy bags to prevent inconsistency would promote the expansion of the market. Another element that supports the industry's growth is the launch of fresh products onto the market by significant rivals.

Based on patient type, the global market is segmented into adult and pediatric.

The adult segment owns the highest market share and is predicted to exhibit a CAGR of 4.9% during the forecast period. It can be explained that fecal incontinence is more likely to develop in older people due to their significantly higher prevalence of neurologic conditions and significantly lower muscle tone than younger ones. In addition, senior people have shorter lives generally than younger people. Additionally, older people's life expectancies are significantly lower than younger people. Compared to older people, people in their younger years have a significantly lower incidence of neurologic problems. This is due to the link between aging and neurologic problems. One possibility that could indicate that people are living longer is that they are living longer as they get older.

Furthermore, a sizable rise in the general population of people over 65 in the key healthcare markets is anticipated to contribute to the business's success. This is because the average age of the US population is rising. The market is expected to grow due to this factor and the number of public-private initiatives to improve patient awareness related to effective incontinence management, increased availability of products for bowel management, and reimbursement in developed countries. This element would specifically influence the market's growth.

Based on end-user, the global market is divided into home care, hospitals, and ambulatory surgery centers. 

The hospital segment is the most significant contributor to the market and is estimated to exhibit a CAGR of 3.6% over the forecast period. Hospitals frequently house the kind of equipment known as comprehensive bowel management systems. Hospitals frequently stock these products due to their ease of use and ability to effectively address various incontinence-related needs. Nursing homes have the largest share of all end users of bowel management devices, followed by hospitals, which account for the second-largest share of all users. This could result from most hospitals offering insurance coverage for various bowel management procedures in addition to meeting the standards for providing other types of treatments. Most of these technologies are used by patients who cannot move independently, which is another reason supporting the growth of the hospital and healthcare sectors.

Recent Developments

• April 2022- Microbiotica received project funding from the Crohn's and Colitis Foundation as a part of their inflammatory bowel disease ventures program to develop therapies to treat inflammatory bowel disease.
• February 2022- Coloplast launched the SenSura Mio in Singapore. SenSura Mio seeks to elevate the standard of living for ostomates, or those who have undergone ostomy and are currently managing a stoma.